Skip to content
Head to head

Lantheus vs Takeda Pharmaceutical

Side-by-side on the measures that matter, with a plain-English read. Full detail: LNTH · TAK

Updated moments ago

1-year performance, rebased to 100

LNTH +94.5%TAK +56.6%
Takeda Pharmaceutical edges it on the scoreable measures. Takeda Pharmaceutical pays the highest dividend yield.
LNTHTAK
Snapshot
SectorDrug Manufacturers - Specialty & Generic--
Last price102.1021.77
Change today+0.00%+1.68%
1-year return+90.5%+57.5%
Market cap$6.68B$69.76B
52-week range54.94 – 111.8613.92 – 22.07
Valuation
P/E (TTM)25.40311.00
P/E percentile, own 5-yr range68th100th
P/B4.931.50
Dividend yield0.00%1.44%
Profitability & growth
EPS (TTM)3.41-0.30
Net profit (TTM)$223.02M$-970.94M
Revenue (TTM)$1.56B$4.69T
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+1.5%+6.7%
Gross margin61.3%65.8%
Operating margin18.6%14.3%
Net margin17.3%0.9%
Free cash flow (TTM)$387.44M$433.95B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership106.9%51.3%
Insider activity (12mo)22 buy / 27 sell19 buy / 31 sell
Short interest (% of float)5.6%0.1%
Analyst consensus100% hold (2)100% buy (1)
Analyst price target$107 (+5%)$50 (+132%)
StockVane view
StockVane Quant RatingC (97)C (90)
Company
Employees1,19347,029
Founded19561781

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.